AU Patent

AU2015353414B2 — Methods and compositions for potentiating the action of opioid analgesics using iboga alkaloids

Assigned to DemeRx Inc · Expires 2021-04-29 · 5y expired

What this patent protects

Methods and compositions for potentiating the effect of an opioid analgesic in a patient undergoing or planning to undergo opioid analgesic therapy using a potentiating amount of iboga alkaloid or pharmaceutically acceptable salt and/or solvate thereof that does not prolong the p…

USPTO Abstract

Methods and compositions for potentiating the effect of an opioid analgesic in a patient undergoing or planning to undergo opioid analgesic therapy using a potentiating amount of iboga alkaloid or pharmaceutically acceptable salt and/or solvate thereof that does not prolong the patient's QT interval by more than about 50 milliseconds.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015353414B2
Jurisdiction
AU
Classification
—
Expires
2021-04-29
Drug substance claim
No
Drug product claim
No
Assignee
DemeRx Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.